[Treatment of benign prostatic hyperplasia in geriatric patients-use and limitations of existing guidelines].
Therapie des benignen Prostatasyndroms beim geriatrischen Patienten – Anwendung und Limitation medizinischer Leitlinien.
Anticoagulation
Benign prostatic hyperplasia
Geriatrics
Lower urinary tract symptoms
Prostate volume
Urinary urge incontinence
Journal
Der Urologe. Ausg. A
ISSN: 1433-0563
Titre abrégé: Urologe A
Pays: Germany
ID NLM: 1304110
Informations de publication
Date de publication:
Sep 2019
Sep 2019
Historique:
entrez:
28
8
2019
pubmed:
28
8
2019
medline:
14
9
2019
Statut:
ppublish
Résumé
The demographic developments of western society and the resulting increase in the number of very old patients in urology represents a challenge for the design of clinical studies and, consequently, recommendations of guidelines. While in internal medicine there is already a subspecialization with a focus on the treatment of elderly and multimorbid patients, in urology there is hardly any subspecialization into the problems of geriatric patients. Thus, using a case study as an example, the treatment decisions for benign prostatic hyperplasia (BPH) in geriatric patients are discussed. In addition the available evidence from the literature and guidelines are presented in order to assiste in daily management of geriatric patients with lower urinary tract symptoms and to critically discuss potential fields of application and limitations of the existing guidelines. In this context, we also examine the challenges when choosing a drug therapy and in deciding which of the many surgical options should be used.
Identifiants
pubmed: 31451881
doi: 10.1007/s00120-019-0988-0
pii: 10.1007/s00120-019-0988-0
doi:
Types de publication
Journal Article
Review
Langues
ger
Sous-ensembles de citation
IM
Pagination
1029-1038Références
BJU Int. 1999 Oct;84(6):622-7
pubmed: 10510105
BJU Int. 2000 Nov;86(7):816-9
pubmed: 11069406
J Wound Ostomy Continence Nurs. 2003 Jul;30(4):231-6
pubmed: 12851599
BJU Int. 2004 Jan;93(1):84-8
pubmed: 14678374
J Am Geriatr Soc. 2004 Feb;52(2):290-6
pubmed: 14728643
Eur Urol. 2004 Aug;46(2):254-62; discussion 263
pubmed: 15245822
BJU Int. 2005 Feb;95(3):354-7
pubmed: 15679793
MMW Fortschr Med. 2005 Oct 13;147(41):45
pubmed: 16270512
BJU Int. 2006 Apr;97(4):727-33
pubmed: 16536763
Drug Saf. 2008;31(5):373-88
pubmed: 18422378
Int J Urol. 2008 Jun;15(6):481-5
pubmed: 18430150
Am J Manag Care. 2008 May;14(5 Suppl 2):S154-9
pubmed: 18611089
Clin Interv Aging. 2008;3(3):511-24
pubmed: 18982921
Eur Urol. 2010 Jan;57(1):123-31
pubmed: 19825505
Int J Clin Pract. 2010 Aug;64(9):1279-86
pubmed: 20529135
Z Gerontol Geriatr. 2013 Jan;46(1):35-47
pubmed: 22618706
J Am Geriatr Soc. 2012 Oct;60(10):E1-E25
pubmed: 22994865
Clinics (Sao Paulo). 2012 Dec;67(12):1415-8
pubmed: 23295595
Aktuelle Urol. 2013 May;44(3):189-95
pubmed: 23712275
Urol Ann. 2015 Jan-Mar;7(1):36-40
pubmed: 25657541
BMJ. 2015 Oct 26;351:h5398
pubmed: 26502947
Ageing Res Rev. 2016 Mar;26:53-61
pubmed: 26674984
J Am Coll Surg. 2016 May;222(5):930-47
pubmed: 27049783
Biomed Res Int. 2016;2016:4975851
pubmed: 27195288
Int Neurourol J. 2016 Jun;20(2):143-50
pubmed: 27377947
Internist (Berl). 2017 Jun;58(6):585-597
pubmed: 28536761
Z Gastroenterol. 2017 Sep;55(9):883-936
pubmed: 29186643
Pharmacoepidemiol Drug Saf. 2018 Mar;27(3):340-348
pubmed: 29316005
Eur Heart J. 2018 Apr 21;39(16):1330-1393
pubmed: 29562325
Urologe A. 2018 Oct;57(10):1257-1270
pubmed: 30225515
Am J Surg. 2019 Aug;218(2):393-400
pubmed: 30509455
Urologe A. 2019 Mar;58(3):254-262
pubmed: 30790004
N Engl J Med. 1997 May 22;336(21):1506-11
pubmed: 9154771
Urology. 1999 Feb;53(2):322-8
pubmed: 9933048